Discover
JSPR
Jasper Therapeutics, Inc.
0.57
2 x 0.41
2 x 0.72
bid
ask
+
0.01
1.82%
2 @ 04:00 PM
0.57 +0.00 (0.00%)
| Ytd | -68.84% | |
| 1y | -77.10% |
0.54
day range
0.58
0.34
52 week range
2.60
| Open | 0.55 | Prev Close | 0.56 | Low | 0.54 | High | 0.58 | Mkt Cap | 18.97M |
| Vol | 261.90K | Avg Vol | 1.37M | EPS | -1.06 | P/E | N/A | Forward P/E | -4.89 |
| Beta | 2.20 | Short Ratio | 9.32 | Inst. Own | 100.34% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-10 | 50-d Avg | 0.67 | 200-d Avg | 0.95 | 1yr Est | 68.78 |
| Income Statement | |||
| Operating Expenses | 9.21M | ||
| Research and Development Expense | 5.14M | ||
| Selling, General and Administrative Expense | 4.07M | ||
| Operating Income | -9.21M | ||
| Net Income | -2.76M | ||
| Net Income Common Stock | -2.76M | ||
| Net Income Common Stock (USD) | -2.76M | ||
| Consolidated Income | -2.76M | ||
| Earnings per Basic Share | -0.10 | ||
| Earnings per Basic Share (USD) | -0.10 | ||
| Earnings per Diluted Share | -0.10 | ||
| Earning Before Interest & Taxes (EBIT) | -2.76M | ||
| Earning Before Interest & Taxes (USD) | -2.76M | ||
| Weighted Average Shares | 28.70M | ||
| Weighted Average Shares Diluted | 28.70M | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.73M | ||
| Cash and Equivalents (USD) | 7.73M | ||
| Current Assets | 11.57M | ||
| Property, Plant & Equipment Net | 188.00K | ||
| Total Assets | 11.80M | ||
| Debt Current | 270.00K | ||
| Total Debt | 270.00K | ||
| Current Liabilities | 7.85M | ||
| Total Liabilities | 10.39M | ||
| Accumulated Retained Earnings (Deficit) | -320.60M | ||
| Shareholders Equity | 1.41M | ||
| Shareholders Equity (USD) | 1.41M | ||
| Assets Non-Current | 231.00K | ||
| Total Debt (USD) | 270.00K | ||
| Liabilities Non-Current | 2.54M | ||
| Trade and Non-Trade Payables | 2.78M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 210.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.83M | ||
| Capital Expenditure | 80.00K | ||
| Net Cash Flow from Investing | 80.00K | ||
| Net Cash Flow from Operations | -6.92M | ||
| Share Based Compensation | 764.00K | ||